Free Trial

Claritev Stockholders OK Directors, PwC and Pay Plan at 2026 Virtual Annual Meeting

Claritev logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • At Claritev's virtual annual meeting on April 29, 2026, stockholders elected four Class III directors — Anthony Colaluca Jr., Michael Klein, Allen Thorpe and Dale White — and approved ratification of PricewaterhouseCoopers as auditor, the advisory say-on-pay, and an amendment to the 2020 Omnibus Incentive Plan.
  • The inspector delivered a preliminary report showing all matters passed; Claritev said it will file the final inspector report and a Form 8‑K with voting results within four business days, and management noted the next earnings call is scheduled for May 7, 2026.
  • Interested in Claritev? Here are five stocks we like better.

Claritev NYSE: CTEV held its 2026 annual meeting of stockholders virtually on April 29, 2026, with Chair and Chief Executive Officer Travis Dalton presiding. Dalton said the company chose to conduct the meeting online again “to enable participation by a broader number of stockholders.”

Meeting attendees and logistics

Dalton introduced the directors in attendance, including Allen Thorpe, the company’s independent lead director and chair of the Nominating and Corporate Governance Committee; Anthony Colaluca Jr., chair of the Audit Committee; Richard Clarke, chair of the Risk Committee; and Julie Klapstein, chair of the Compensation Committee. He also named directors Martin Harris, Jason Kap, Michael Klein, John Prince, and Dale White.

Amir Collins of PricewaterhouseCoopers attended on behalf of the company’s independent auditors and was identified as available to respond to appropriate questions during the question-and-answer period. Kent Bartholomew, the company’s corporate secretary, served as secretary of the meeting.

According to Dalton, the meeting was recorded and would be made available for replay on Claritev’s investor relations website. He also outlined procedures for submitting questions and voting during the virtual session.

Quorum confirmed and polls opened

Dalton called the meeting to order at 9:03 a.m. on April 29 and said Lou Larson had been appointed as inspector of election. Dalton reported that Broadridge had delivered an affidavit of distribution stating that the notice of availability of proxy materials began mailing on March 20, 2026, and that the stockholder list as of March 6, 2026, had been on file at the company’s principal office for at least 10 days. Dalton said he had been informed that a quorum was present and declared the meeting “fully convened.”

The company opened polls for four proposals, with Dalton noting that stockholders could vote online through the closing of the polls.

Four proposals presented to stockholders

Dalton reviewed the meeting’s four items of business:

  • Director elections: Stockholders voted on the election of four Class III nominees to serve until the 2029 annual meeting or until successors are duly elected and qualified. The nominees were Anthony Colaluca Jr., Michael Klein, Allen Thorpe, and Dale White. Dalton said no other nominations were received prior to the deadline under the company’s bylaws and that no additional nominations could be made at the meeting.
  • Auditor ratification: A vote to ratify PricewaterhouseCoopers LLP as Claritev’s independent registered public accounting firm for fiscal year 2026.
  • Say-on-pay: An advisory vote to approve compensation of the company’s named executive officers.
  • Equity plan amendment: A vote to approve an amendment to the Claritev Corporation 2020 Omnibus Incentive Plan.

When asked whether there were questions regarding the proposals, the operator responded that there were none.

Voting results and next steps

The polls closed at 9:05 a.m. Dalton said the inspector of election delivered a preliminary report showing stockholders approved each matter presented. “Each of the four nominees for class three director have been elected,” Dalton said, adding that the proposals to ratify PwC, approve the say-on-pay advisory measure, and amend the 2020 omnibus incentive plan “have all been approved.”

Dalton said the company would file the final report of the inspector of election with the meeting’s records and expected to report voting results in a Form 8-K to be filed with the Securities and Exchange Commission within four business days.

Meeting adjourned; earnings call date noted

With no further business brought before the meeting under the company’s bylaws, Dalton adjourned the session and thanked stockholders for their continued support. He also pointed to the company’s next scheduled update, saying he and Chief Financial Officer Doug Garis looked forward to sharing information on the next earnings call on Thursday, May 7, 2026.

About Claritev NYSE: CTEV

Claritev is a healthcare technology, data and insights company focused on improving affordability,  transparency and quality. Led by deeply experienced associates, data scientists, and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources from over 40 years of claims repricing. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Claritev Right Now?

Before you consider Claritev, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Claritev wasn't on the list.

While Claritev currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines